1 |
顾敏,廖中凯,石丽,等. 心脏移植术后神经系统并发症研究进展[J/CD]. 中华移植杂志:电子版,2020,14(4):255-257.
|
2 |
Weiss N, Thabut D. Neurological complications occurring after liver transplantation: role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury[J]. Liver Transpl, 2019,25(3):469-487.
|
3 |
Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease[J]. Nat Rev Neurol, 2021,17(1):37-51.
|
4 |
Manz HJ, Dinsdale HB, Morrin PA. Progressive multifocal leukoencephalopathy after renal transplantation. Demonstration of Papova-like virions[J]. Ann Intern Med, 1971,75(1):77-81.
|
5 |
Moreno-Estébanez A, Almeida Velasco J, Pérez-Concha T, et al. Progressive multifocal leukoencephalopathy 11 years after liver transplantation: a case report[J]. J Neurovirol, 2017,23(6):929-931.
|
6 |
Rastogi A, Gulati N, Bihari Chhagan, et al. JC virus-related progressive multifocal leukoencephalopathy after living-donor liver transplant: A rare case[J]. Exp Clin Transplant, 2019,17(3):414-417.
|
7 |
Dumortier J, Guillaud O, Bosch A, et al. Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome[J]. Transpl Infect Dis, 2016,18(4):606-610.
|
8 |
Neff RT, Hurst FP, Falta EM, et al. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation[J]. Transplantation, 2008,86(10):1474-1478.
|
9 |
Lippa AM, Ocwieja KE, Iglesias J, et al. Progressive multifocal leukoencephalopathy presenting with acute sensorineural hearing loss in an intestinal transplant recipient[J]. Transpl Infect Dis, 2020,22(4):e13304.
|
10 |
Shitrit D, Lev N, Bar-Gil-Shitrit A, et al. Progressive multifocal leukoencephalopathy in transplant recipients[J]. Transpl Int, 2005,17(11):658-665.
|
11 |
Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients[J]. Ann Neurol, 2011,70(2):305-322.
|
12 |
Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project[J]. Blood, 2009,113(20):4834-4840.
|
13 |
Windpessl M, Burgstaller S, Kronbichler A, et al. Progressive multifocal leukoencephalopathy following combined rituximab-based immune-chemotherapy for post-transplant lymphoproliferative disorder in a renal transplant recipient: a case report[J]. Transplant Proc, 2018,50(3):881-883.
|
14 |
Pavlovic D, Patera AC, Nyberg F, et al. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives[J]. Ther Adv Neurol Disord, 2015,8(6):255-273.
|
15 |
Ishii K, Yamamoto F, Homma S, et al. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review[J]. BMC Neurol, 2019,19(1):263.
|
16 |
Cortese I, Muranski P, Enose-Akahata Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy[J]. N Engl J Med, 2019,380(17):1597-1605.
|
17 |
Hoang E, Bartlett NL, Goyal MS, et al. Progressive multifocal leukoencephalopathy treated with nivolumab[J]. J Neurovirol, 2019,25(2):284-287.
|
18 |
Medrano C, Vergez F, Mengelle C, et al. Effectiveness of immune checkpoint inhibitors in transplant recipients with progressive multifocal leukoencephalopathy[J]. Emerg Infect Dis, 2019,25(11):2145-2147.
|
19 |
Lindzen E, Gilani A, Markovic-Plese S, et al. Acute disseminated encephalomyelitis after liver transplantation[J]. Arch Neurol, 2005,62(4):650-652.
|
20 |
Horowitz MB, Comey C, Hirsch W, et al. Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report[J]. Neuroradiology, 1995,37(6):434-437.
|
21 |
Kim SC, Jang HJ, Han DJ. Acute disseminated encephalomyelitis after renal transplantation in patients with positive Epstein-Barr virus antibody[J]. Transplant Proc, 1998,30(7):3139.
|
22 |
Iwanaga T, Ooboshi H, Imamura T, et al. A case of acute disseminated encephalomyelitis after renal transplantation[J]. Rinsho Shinkeigaku, 2001,41(11):792-796.[Article in Japanese]
|
23 |
Caucheteux N, Maarouf A, Daelman L, et al. Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?[J]. Mult Scler, 2013, 19(9):1222-1225.
|
24 |
Aboagye-Kumi M, Yango A Jr, Fischer S, et al. Acute disseminated encephalomyelitis in a renal transplant recipient: a case report[J]. Transplant Proc, 2008,40(5):1751-1753.
|
25 |
Lambeck J, Hieber M, Dreßing A, et al. Central pontine myelinosis and osmotic demyelination syndrome[J]. Dtsch Arztebl Int, 2019,116(35-36):600-606.
|
26 |
Morard I, Gasche Y, Kneteman M, et al. Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study[J]. Neurocrit Care, 2014,20(2):287-295.
|
27 |
Cascales Campos P, Ramirez P, Gonzalez R, et al. Central pontine and extrapontine myelinolysis: a rare and fatal complication after liver transplantation[J]. Transplant Proc, 2011,43(6):2237-2238.
|
28 |
Crivellin C, Cagnin A, Manara R, et al. Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study[J]. Transplantation, 2015,99(6):1257-1264.
|
29 |
Lee EM, Kang JK, Yun SC, et al. Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation[J]. Eur Neurol, 2009,62(6):362-368.
|
30 |
Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review[J]. Eur J Neurol, 2014,21(12):1443-1450.
|
31 |
Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review[J]. Mult Scler Relat Disord, 2017,14:72-79.
|
32 |
Wan DL, Ren KW, Zhang LL, et al. Liver transplant recipient with tumefactive demyelinating lesions: A case report and literature review[J]. Transplant Proc, 2016,48(9):3197-3202.
|